tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Schmidt, 150 are a BUY (78.13%), 42 are a HOLD (21.88%).
Analyst Michael Schmidt, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 53.75% that have a potential upside of 54.55% achieved within 260 days.
Michael Schmidt’s has documented 397 price targets and ratings displayed on 47 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RVMD, Revolution Medicines at 25-Jun-2025.
Analyst best performing recommendations are on MRSN (MERSANA THERAPEUTICS).
The best stock recommendation documented was for MRSN (MERSANA THERAPEUTICS) at 5/16/2025. The price target of $5 was fulfilled within 73 days with a profit of $4.66 (1370.59%) receiving and performance score of 187.75.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$4
3 years 1 months 19 days ago
(14-Jun-2022)
0/11 (0%)
$2.53 (172.11%)
Hold
$4.75
$4.66 (5177.78%)
$5.75
3 years 8 months 30 days ago
(03-Nov-2021)
10/12 (83.33%)
$0.06 (1.28%)
65
Sell
4 years 8 months 27 days ago
(06-Nov-2020)
3/5 (60%)
$5.73 (134.19%)
42
Buy
$16
$15.91 (17677.78%)
$17
4 years 11 months 26 days ago
(07-Aug-2020)
5/12 (41.67%)
$10.58 (195.20%)
77
Sell
$4
$3.91 (4344.44%)
$3
5 years 2 months 27 days ago
(06-May-2020)
3/5 (60%)
$-4.07 (-50.43%)
191
Which stock is Michael Schmidt is most bullish on?
Which stock is Michael Schmidt is most reserved on?
What Year was the first public recommendation made by Michael Schmidt?
